צמיחת רווח למניה משנה לשנה בשנים עשר החודשים האחרונים: IO Biotech, Inc. (IOBT)

IO Biotech, Inc. (IOBT) is implementing ESG standards by reducing chemical waste during drug development. On GURU.Markets, historical quarterly EPS growth demonstrates profit dynamics, where 0.00 captures the magnitude of this parameter. The brand is highly valued in the US and Denmark for its innovations in combating metastases. Flawless cold-chain logistics ensure the timely delivery of vaccines for testing.

This indicator measures the annual change in net profit per share on a quarterly basis. The formula captures earnings dynamics that are sensitive to any fluctuations in operating expenses and one-time payments. The quarterly EPS growth trajectory on the GURU.Markets platform visualizes market momentum and the risk of asset overvaluation. For IO Biotech, Inc. (IOBT), the volatility of this metric is driven by large-scale R&D investments and stock option programs for leading scientists. High costs associated with retaining PhD specialists directly determine the amplitude of this indicator.